Publication of transparency notifications

Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares are admitted to trading on a regulated market Press release - regulated information Biotalys NV ( Euronext Brussel : BTLS ) (the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, announces today, in accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings...

Ghent, 23/10/2024 (informazione.it - comunicati stampa - cibi e bevande)

Press release - regulated information

Biotalys NV ( Euronext Brussel : BTLS ) (the “Company” or “Biotalys”), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, announces today, in accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings in issuers whose shares are admitted to trading on a regulated market (the 'Belgian Transparency Act'), that it has received transparency notifications from Ackermans & van Haaren NV, Agri Investment Fund BV, Gimv NV and Biotech Fonds Vlaanderen NV, ParticipatieMaatschappij Vlaanderen NV, K&E BV and RMM SA.

1.    Ackermans & van Haaren NV


Ackermans & van Haaren NV has announced that, on 16 October 2024, it held 5,783,065 shares of Biotalys NV, representing 15.44% of the total number of voting rights.

The notification dated 18 October 2024 contains the following information:

In accordance with article 11, §1 of the Act of 2 May 2007, stichting administratiekantoor “Het Torentje” acts in its own name and on behalf of the companies set forth under (ii) up to and including (vi).

2.    Agri Investment Fund BV

Agri Investment Fund C.V.B.A. has announced that, on 16 October 2024, it held 4,736,390 shares of Biotalys NV, representing 12.64% of the total number of voting rights.

The notification dated 22 October 2024 contains the following information:

3.    Gimv NV and Biotech Fonds Vlaanderen NV


Gimv NV and Biotech Fonds Vlaanderen NV have announced that, on 16 October 2024, combined they held 4,307,393 shares of Biotalys NV, representing 11.50% of the total number of voting rights.

The notification dated 22 October 2024 contains the following information:

4.    ParticipatieMaatschappij Vlaanderen NV

ParticipatieMaatschappij Vlaanderen NV has announced that, on 18 October 2024, it held 1,847,329 shares of Biotalys NV, representing 4.93% of the total number of voting rights.

The notification dated 22 October 2024 contains the following information:

5.    K&E BV


K&E BV has announced that, on 16 October 2024, it held 1,823,003 shares of Biotalys NV, representing 4.87% of the total number of voting rights.

The notification dated 21 October 2024 contains the following information:

6.    RMM SA

RMM SA has announced that, on 16 October 2024, it held 1,815,465 shares of Biotalys NV, representing 4,85% of the total number of voting rights.

The notification dated 21 October 2024 contains the following information:

The respective transparency notifications can be found on www.biotalys.com/investors .

About Biotalys

Biotalys is an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for the protection of crops and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and has been listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com .

For further information, please contact:

Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: IR@biotalys.com

Attachments